Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor
Together, our study provides the rationale and critical data for a prospective clinical trial of PRG-N-01 in NF2-SWN patients indicating PRG-N-01 as a promising candidate for the treatment.
Authors
- Jin Han (ORCID: https://orcid.org/0000-0003-1859-3425)
- Moon Young Lee (ORCID: https://orcid.org/0000-0003-4956-9241)
- Yeon‐Ho Chung (ORCID: https://orcid.org/0009-0000-9035-7932)
- Tae‐Gyun Woo (ORCID: https://orcid.org/0000-0002-6957-0998)
- Yeongseon Ji
- Eun‐Soon Shin (ORCID: https://orcid.org/0000-0001-8408-2696)
- Bum-Joon Park (ORCID: https://orcid.org/0000-0002-6037-7219)
- Bae-Hoon Kim (ORCID: https://orcid.org/0000-0001-6866-7248)
- Young Jun Hwang
- Yuju Kim
- Seung-Jin Baek (ORCID: https://orcid.org/0000-0003-0494-2372)
- Jungmin Choi (ORCID: https://orcid.org/0000-0002-8614-0973)
- Hong‐Rae Kim (ORCID: https://orcid.org/0000-0001-5361-7168)
- So‐Young Park (ORCID: https://orcid.org/0000-0002-5224-3077)
- Minju Kim (ORCID: https://orcid.org/0000-0003-4612-7624)
- Jong Won Lee (ORCID: https://orcid.org/0000-0002-2203-3634)
- Yi Jin Song
Institutions
- Korea University (KR)
- St. Mary's Medical Center (US)
- Korea University (JP)
- Pusan National University (KR)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2024-12-28
- DOI
- https://doi.org/10.1093/neuonc/noae282
- Citations
- 3
- Primary Topic
- Neurofibromatosis and Schwannoma Cases
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- National Research Foundation
- Yonsei University
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Yonsei University College of Medicine